cover
Contact Name
Mochamad Nashrullah
Contact Email
Nashrul.id@gmail.com
Phone
+6285136040851
Journal Mail Official
Nashrul.id@gmail.com
Editorial Address
Kavling Banar, Pilang, Sidoarjo, Jawa Timur
Location
Kab. sidoarjo,
Jawa timur
INDONESIA
Journal of Medical Genetics and Clinical Biology (JMGCB)
Published by Antis Publisher
ISSN : -     EISSN : 30321085     DOI : https://doi.org/10.61796/jmgcB
Core Subject : Health, Science,
Journal of Medical Genetics and Clinical Biology is a peer-reviewed forum for advances at the intersection of human genetics and clinical medicine. The journal welcomes original research, reviews, brief reports, and case reports that translate genomic discoveries into clinical utility—spanning diagnostic workflows, risk stratification, therapeutic decision-making, and implementation in real-world care. Areas of interest include Mendelian and complex disorders, cancer genetics, pharmacogenomics, biomarkers, clinical genomics (panel testing, WES/WGS), bioinformatics and data integration, as well as ethical and counseling considerations. By bridging molecular insights and bedside applications, the journal aims to support precision health and improve outcomes across diverse patient populations.
Articles 389 Documents
COVID-19–RELATED LUNG INJURY: A HISTOPATHOLOGICAL OVERVIEW Alkhirsan, Zainab M Jawad; Alyasiry, Esraa A.; Abdulhadi, Ali M Hussein
Journal of Medical Genetics and Clinical Biology Vol. 3 No. 1 (2026): Journal of Medical Genetics and Clinical Biology
Publisher : PT. Antis International Publisher

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.61796/jmgcb.v3i1.1601

Abstract

Objective: To provide a comprehensive review of the key histopathological features associated with COVID-19–related lung injury and to clarify the extent of vascular and inflammatory involvement in the disease. Method: A literature review analyzing reported histopathological findings in COVID-19 lung specimens, comparing them with other viral infections such as H1N1 influenza, and correlating them with clinical and radiological data. Results: Findings consistently highlight diffuse alveolar damage (exudative and proliferative phases), type II pneumocyte hyperplasia, squamous metaplasia, intra-alveolar hemorrhage, microthrombosis, and occasional osseous metaplasia. Additional observations include inflammatory infiltrates, endothelial injury, and cytokine-related damage (e.g., IL-6 upregulation). COVID-19 shows more extensive alveolar and vascular involvement than many other viral infections, though findings vary across patients and comorbidities. Novelty: The review underscores that although several histopathological features overlap with other viral pneumonias, the severity of vascular injury and the complexity of the inflammatory response in COVID-19 distinguish it. It also stresses the diagnostic value of integrating histopathological, clinical, and radiological evidence to better understand disease pathogenesis.
REPURPOSING ORLISTAT AS A FATTY ACID SYNTHASE INHIBITOR IN BREAST CANCER: IN VITRO EFFICACY, MECHANISMS, AND SYNERGY WITH DOXORUBICIN Rasool, Abeer Mansour Abdel; Rashid, Ammar M. Sheet; Hassan , Emad Hussein Ahmad; Subhi, Abdulhameed
Journal of Medical Genetics and Clinical Biology Vol. 3 No. 1 (2026): Journal of Medical Genetics and Clinical Biology
Publisher : PT. Antis International Publisher

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.61796/jmgcb.v3i1.1606

Abstract

Objective: This study investigates the therapeutic potential of repurposing Orlistat, a potent irreversible inhibitor of fatty acid synthase (FASN), to enhance cytotoxic efficacy against breast cancer cells, both independently and in combination with doxorubicin. Method: Estrogen receptor-positive MCF-7 and triple-negative MDA-MB-231 cells were treated with Orlistat and doxorubicin individually and jointly, followed by assessments of cell viability (MTT), FASN expression (qRT-PCR and Western blot), apoptosis (Annexin V-FITC/PI flow cytometry and cleaved caspase-3), and drug interactions using the Chou–Talalay combination index. Results: Orlistat monotherapy significantly reduced cell viability in a dose-dependent manner, induced G1 arrest and apoptosis, and suppressed FASN expression and lipid accumulation, confirming metabolic targeting. Doxorubicin alone produced expected cytotoxicity, whereas the Orlistat–doxorubicin combination yielded synergistic inhibition (CI < 1) with markedly enhanced apoptotic signaling. Novelty: This work demonstrates, for the first time, a robust synergistic interaction between Orlistat and doxorubicin through coordinated disruption of lipid metabolism and heightened apoptotic induction, highlighting Orlistat’s promise as a metabolic adjuvant to improve breast cancer chemotherapeutic responses.
AN EMERGING UROPATHOGENIC THREAT: HIGH-VIRULENCE, STRESS-ADAPTED, AND DRUG-RESISTANT PSEUDOMONAS AERUGINOSA FROM CLINICAL UTI IRAQI ISOLATES Alyaa Jabbar Qasim; Eman Thamer Garallah; Dijlah A. Alimeer
Journal of Medical Genetics and Clinical Biology Vol. 3 No. 8 (2026): Journal of Medical Genetics and Clinical Biology
Publisher : PT. Antis International Publisher

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.61796/jmgcb.v3i8.1886

Abstract

Objective: Pseudomonas aeruginosa is one of the most important urinary tract infection-causative pathogens that is greatly associated with Urinary Tract Infections (UTI) because of its great ability to adaptation at different harsh environments due to the presence of a set of genes that contribute to the expression of virulence factors and the development of antibiotic resistance. The present study aimed to phenotypically characterize the multidimensional phenotypic profile of Pseudomonas aeruginosa isolated from UTI Iraqi patients. Methods: Attachment and biofilm formation, blood hemolysis, urease, lipase, gelatinase, protease, and siderophores producing all were evaluated as virulence factors. Isolates' tolerance to harsh conditions, including heat, cold, salt, acid, and alkaline, was estimated. Antibiotic susceptibility test have been performed to assess isolates resistance against pipracillin, ceftazidime, cefepime, azteronam, imipenem, meropenem, amikacin, gentamicin, tobramycin, levofloxacin and colistin. Results: Results explain that the majority of isolates had a concurrent presence of virulence traits and the ability for antibiotic resistance and tolerance to harsh conditions. Novelty: which indicate that Pseudomonas aeruginosa represents an emerging uropthological threat characterized by high adaptive flexibility and virulence, which further complicates therapeutic options and underscores the need for continuous surveillance and more stringent preventive and therapeutic strategies to limit their spread in clinical settings.
METHODOLOGICAL ADVANCEMENTS IN ANTIMICROBIAL SCREENING OF MEDICINAL PLANTS: A CRITICAL APPRAISAL OF EXTRACTION, PHYTOCHEMICAL, AND SUSCEPTIBILITY PROTOCOL Raghad Hatem Mohammed
Journal of Medical Genetics and Clinical Biology Vol. 3 No. 8 (2026): Journal of Medical Genetics and Clinical Biology
Publisher : PT. Antis International Publisher

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.61796/jmgcb.v3i8.1887

Abstract

Objective: This review provides a critical assessment of the experimental workflow adopted in medicinal plant antimicrobial screening from plant choice and extraction to phytochemical characterisation, in vitro susceptibility testing, anti-virulence and synergy testing, mode of action and toxicological assessment. Method: Traditional extraction methods including maceration, Soxhlet extraction and hydrodistillation are contrasted with more recent methodologies such as ultrasound-assisted extraction and green solvents comprising natural deep eutectic solvents in terms of yield, selectivity and stability of thermolabile components. Qualitative phytochemical tests and chromatographic identification techniques are reviewed along with their drawbacks in the verification of bioactivity. Results: weaknesses that were continually noted throughout the literature included: variable reporting of the concentration of extracts; non-standardised inoculum size and growth media; positive and negative controls not being used when applicable., and inadequate focus on reproducibility and specificity. Novelty: Methodological harmonisation to enhance the translational value of future investigations in this area is proposed. Recommendations are provided for the methodological harmonisation to enhance the translational value of futures studies in this area.
DEVELOPMENT AND SYNTHESIS OF NEW TINIDAZOLE-BASED NITRONE DERIVATIVES: STRUCTURAL CHARACTERIZATION AND IN VITRO BIOLOGICAL EVALUATION Mohammed Abbas Hussein; Raheem Jameel Mohaisen
Journal of Medical Genetics and Clinical Biology Vol. 3 No. 8 (2026): Journal of Medical Genetics and Clinical Biology
Publisher : PT. Antis International Publisher

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.61796/jmgcb.v3i8.1891

Abstract

Objective: The rapid emergence of multi-drug resistant (MDR) bacterial pathogens has intensified the search for novel antimicrobial scaffolds. This study reports the design, synthesis, and biological evaluation of a new series of nitrone derivatives based on the Tinidazole scaffold. Methods: A library of compounds (M1–M3) was synthesized via the condensation of various aryl-substituted benzaldehydes with tinidazole-derived hydroxylamine intermediates. The molecular structures and stereochemical configurations of the synthesized hybrids were rigorously confirmed using spectral characterization techniques, including FT-IR, 1H NMR, 13C NMR, and Mass Spectrometry, which consistently indicated the formation of the stable (Z)-isomeric form. Results: The in vitro biological evaluation revealed that these nitrone derivatives possess potent broad-spectrum antibacterial activity against Gram-positive (Staphylococcus aureus) and Gram-negative (Klebsiella pneumoniae) clinical isolates. Notably, compounds M1 (4-F), M2 (H), and M3 (4-Br) exhibited exceptional zones of inhibition (ZOI) ranging from 41 to 46 mm at the highest concentrations, significantly outperforming the standard drug (ST), which reached a maximum ZOI of 22 mm. Furthermore, the compounds demonstrated significant antioxidant potential in the DPPH radical scavenging assay. Novelty: The Structure-Activity Relationship (SAR) analysis suggests that the electronic and lipophilic modulation of the aryl-substituted nitrone framework, particularly with halogenated substituents, plays a pivotal role in enhancing membrane permeability and bactericidal efficacy. These findings position tinidazole-based nitrones as highly promising candidates for the development of next-generation antimicrobial agents to combat resistant pathogens.
MOLECULAR DETECTION OF NANA AND NANB VIRULENCE GENES IN CLINICAL STREPTOCOCCUS PNEUMONIAE ISOLATES FROM PATIENTS WITH PNEUMONIA AND THEIR ASSOCIATION WITH DISEASE SEVERITY Hamzah Shakir
Journal of Medical Genetics and Clinical Biology Vol. 3 No. 8 (2026): Journal of Medical Genetics and Clinical Biology
Publisher : PT. Antis International Publisher

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.61796/jmgcb.v3i8.1895

Abstract

Objective: The goal of the study was to molecularly identify the neuraminidase-code genes nanA and nanB in clinical S. pneumoniae isolates obtained in patients with the pneumonia and to determine their relationship with the degree of disease severity. Method: One hundred and twenty clinical isolates were taken from hospitalized patients with positive pneumonia. The traditional PCR technique was used to confirm the identification of isolates using conventional microbiological methods. The relationship, co-occurrence patterns and the prevalence of nanA and nanB genes with clinical severity indicators were studied. Results: The nanA and nanB genes were detected in 91.7% and 74.2% of the isolates, respectively, with both genes present in 68.3% of the isolates. NanB alone and isolates carrying both nanA and nanB had a significant positive correlation with increased severity scores, increased levels of inflammatory drugs and higher intensive care unit (ICU) admission rates. Novelty: The results highlight the possible usefulness of the neuraminidase gene profiling as a prognostic system in the management of pneumococcal pneumonia.
MOLECULAR CHARACTERIZATION OF VIRULENCE-ASSOCIATED TOXIN GENES IN CLINICAL METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS (MRSA) ISOLATES FROM WOUND INFECTIONS Hamzah Shakir
Journal of Medical Genetics and Clinical Biology Vol. 3 No. 8 (2026): Journal of Medical Genetics and Clinical Biology
Publisher : PT. Antis International Publisher

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.61796/jmgcb.v3i8.1896

Abstract

Objective: The aim of the present study was to molecularly characterize the MRSA isolates obtained through wound infection specimens, with a special concern on the identification of the mecA resistance gene and the presence of the major toxin genes such as Panton-Valentine Leukocidin (lukSF-PV), toxic shock syndrome toxin-1 (tst) and staphylococcal enterotoxins (sea, seb). Method: Wound swabs were treated with common bacteriological procedures and confirmed Staphylococcus aureus isolates were subjected to antimicrobial susceptibility testing and then to multiplex polymerase chain reaction (PCR) to be molecularly characterized. Results: Findings indicated that there was a significant prevalence of mecA-positive MRSA isolates in wound infection specimens and there was a high level of co-carriage of toxin genes most notably lukSF-PV and tst. These two characteristics (resistance and virulence determinants) of wound-related strains of MRSA highlight the dual risks that such strains present to patient and infection control. Novelty: The results highlight the significant importance of molecular diagnostic techniques in combination with regular clinical microbiology practice to facilitate proper identification of MRSA and influence clinical decision-making, as well as epidemiological monitoring.
MOBILE GENETIC ELEMENTS IN MICROBIAL GENETICS: MECHANISMS OF HORIZONTAL GENE TRANSFER AND THEIR ROLE IN THE EVOLUTION OF ANTIMICROBIAL RESISTANCE: A MINI REVIEW Lubna Abdulazeem
Journal of Medical Genetics and Clinical Biology Vol. 3 No. 8 (2026): Journal of Medical Genetics and Clinical Biology
Publisher : PT. Antis International Publisher

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.61796/jmgcb.v3i8.1900

Abstract

Objective: This mini-review discusses the major types of mobile genetic elements (MGEs), their molecular mechanisms of mobility, their role in horizontal gene transfer, and their contribution to the evolution and dissemination of antimicrobial resistance in microbial populations. Method: The review applies a structured narrative synthesis of the peer-reviewed articles, standard microbiology references, and international surveillance reports cited in the manuscript. Evidence was organized thematically around microbial genome organization, horizontal gene transfer, major MGE classes, genomic islands, antimicrobial resistance dissemination, and genomic approaches for MGE detection and surveillance. Results: The literature indicates that plasmids, transposons, insertion sequences, integrons, integrative and conjugative elements, bacteriophages, and genomic islands form interconnected genetic vehicles that accelerate the acquisition and spread of resistance, virulence, and adaptive traits. Whole-genome sequencing, metagenomics, comparative genomics, and bioinformatics increasingly enable high-resolution tracking of these elements, while CRISPR-Cas systems influence the interaction between microbes and mobile DNA. Novelty: This review integrates the molecular mechanisms, genomic architecture, antimicrobial-resistance consequences, and surveillance implications of MGEs within a single concise framework and highlights their relevance to clinical microbiology, environmental microbiology, and biotechnology.
COMPARATIVE IN VITRO EVALUATION OF ADMA AND NITROGLYCERIN, ALONE AND COMBINED WITH DOXORUBICIN, ON TOTAL ANTIOXIDANT CAPACITY IN BREAST CANCER CELL LINES Hind A. Abdulghafoor
Journal of Medical Genetics and Clinical Biology Vol. 3 No. 9 (2026): Journal of Medical Genetics and Clinical Biology
Publisher : PT. Antis International Publisher

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.61796/jmgcb.v3i9.1912

Abstract

Objective: Breast cancer cell lines differ in basal redox prominence and antioxidant defense capacity, which may influence their response to chemotherapeutic traffickers and nitric oxide-related modulators with respect to total antioxidant capacity (T-AOC) in breast cancer cell models administered alone or in combination with doxorubicin in alcohol dimethylarginine (ADMA) and nitroglycerin MCF-7, CAL-51, and MDA-MB-231 cells were screened for mobile tracers of breast cancer, cells containing rat embryonic fibroblast (REF) cells as non-tumor comparators. Method: Untreated controls, ADMA, and nitroglycerine were as well as doxorubicin. T-AOC-associated absorbance was measured at 593 nm using the Fe³⁺-TPTZ reduction method. Data were analyzed using two-way analysis of variance followed by the least significant difference test. Results: The treatments produced distinct responses across the examined cell models. The nitroglycerin–doxorubicin combination reduced T-AOC in REF and MCF-7 cells but increased it in CAL-51 cells. ADMA alone produced the highest response in MCF-7 cells, whereas doxorubicin alone generated the highest value in MDA-MB-231 cells. Nitroglycerin alone produced relatively low T-AOC values in CAL-51 and MDA-MB-231 cells. These results indicate that the direction and value of the antioxidant response differ by cell type and process. Novelty: ADMA, nitroglycerin, and doxorubicin precipitated cell line-dependent changes in total antioxidant capacity. The opposite responses for the mixed treatment indicate that the mobile history affects the redox variation for those elements. Complementary oxidative stress and cell viability assays are required to determine the mechanisms underlying these adaptations.
HELICOBACTER PYLORI INFECTION: FROM BIOLOGICAL CHARACTERISTICS AND GASTROINTESTINAL PATHOGENESIS TO DIAGNOSIS AND TREATMENT—A COMPREHENSIVE REVIEW Walaa Najah Majid; Sheereehan Abdullhussein Albyati
Journal of Medical Genetics and Clinical Biology Vol. 3 No. 9 (2026): Journal of Medical Genetics and Clinical Biology
Publisher : PT. Antis International Publisher

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.61796/jmgcb.v3i9.1921

Abstract

Objective: Understanding why H. pylori can occasionally be a deadly infection and figuring out how to get rid of it in those who are most at risk for serious illness are crucial in this second decade of rigorous study. Method: The biology of H. pylori colonization, stomach and intestinal microbiota, mucosal damage mechanisms, major gastrointestinal disorders, gastric carcinogenesis, diagnostic techniques, antibiotic resistance, and current eradication options are all covered in this narrative overiew. Results: Over the last decade, Helicobacter pylori has become one of the most common human infection, infecting practically everyone who has been exposed to filthy conditions from infancy. It is also found among high socioeconomic classes but less commonly. H. pylori is an important factor in the pathogenesis of duodenal and, to a lesser extent, gastric ulcers in addition to inducing chronic active gastritis. Furthermore, this bacteria is now considered as a risk factor for lymphoma and stomach cancer. However, the majority of infections don't have any clinical effects. Novelty: Improving long-term gastrointestinal health, therapy selection, and prevention all depend on an understanding of this integrated host-microbe connection.

Filter by Year

2024 2026


Filter By Issues
All Issue Vol. 3 No. 10 (2026): Journal of Medical Genetics and Clinical Biology Vol. 3 No. 9 (2026): Journal of Medical Genetics and Clinical Biology Vol. 3 No. 8 (2026): Journal of Medical Genetics and Clinical Biology Vol. 3 No. 7 (2026): Journal of Medical Genetics and Clinical Biology Vol. 3 No. 1 (2026): Journal of Medical Genetics and Clinical Biology Vol. 2 No. 12 (2025): Journal of Medical Genetics and Clinical Biology Vol. 2 No. 11 (2025): Journal of Medical Genetics and Clinical Biology Vol. 2 No. 10 (2025): Journal of Medical Genetics and Clinical Biology Vol. 2 No. 9 (2025): Journal of Medical Genetics and Clinical Biology Vol. 2 No. 8 (2025): Journal of Medical Genetics and Clinical Biology Vol. 2 No. 7 (2025): Journal of Medical Genetics and Clinical Biology Vol. 2 No. 6 (2025): Journal of Medical Genetics and Clinical Biology Vol. 2 No. 5 (2025): Journal of Medical Genetics and Clinical Biology Vol. 2 No. 4 (2025): Journal of Medical Genetics and Clinical Biology Vol. 2 No. 3 (2025): Journal of Medical Genetics and Clinical Biology Vol. 2 No. 2 (2025): Journal of Medical Genetics and Clinical Biology Vol. 2 No. 1 (2025): Journal of Medical Genetics and Clinical Biology Vol. 1 No. 12 (2024): Journal of Medical Genetics and Clinical Biology Vol. 1 No. 11 (2024): Journal of Medical Genetics and Clinical Biology Vol. 1 No. 10 (2024): Journal of Medical Genetics and Clinical Biology Vol. 1 No. 9 (2024): Journal of Medical Genetics and Clinical Biology Vol. 1 No. 8 (2024): Journal of Medical Genetics and Clinical Biology Vol. 1 No. 7 (2024): Journal of Medical Genetics and Clinical Biology Vol. 1 No. 6 (2024): Journal of Medical Genetics and Clinical Biology Vol. 1 No. 5 (2024): Journal of Medical Genetics and Clinical Biology Vol. 1 No. 4 (2024): Journal of Medical Genetics and Clinical Biology Vol. 1 No. 3 (2024): Journal of Medical Genetics and Clinical Biology Vol. 1 No. 2 (2024): Journal of Medical Genetics and Clinical Biology Vol. 1 No. 1 (2024): Journal of Medical Genetics and Clinical Biology More Issue